Welcome to the Bureau for COPD Research and Education to Advance Therapeutic Excellence (BREATHE) Xchange Webcast and live expert Q&A discussion series. The BREATHE-Xchange Webcast series offers a forum for a live discussion with some of today's most well-known respiratory opinion leaders.
This 3-part Webcast series discusses the role of Perforomist® (formoterol fumarate) Inhalation Solution as an innovative, long-acting, twice-daily nebulized therapy that addresses a need in the maintenance treatment of COPD. This program will also provide an overview of the burden and progression of COPD, as well as the current rationale supporting evidence-based treatment. Additionally, this educational forum will discuss and evaluate the clinical implications of key data establishing the efficacy, safety, and sustained performance of Perforomist® Solution, both alone and as an add-on therapy with maintenance Spiriva® (tiotropium bromide inhalation powder) HandiHaler®. Lastly, this program will define the characteristics and profile of ideal patient candidates for treatment with Perforomist® Solution, and will identify strategies for broader utilization of nebulized therapy in clinical practice.
Each 30-minute Webcast will include a 20-minute presentation of key clinical data and a live 10-minute interactive Q&A discussion with the faculty presenter.
If you have not already done so, we encourage you to register for the live programs taking place beginning October 7, 2009. To view the calendar of live programs, click here.
This COPD Webcast series is brought to you by